Rankings
▼
Calendar
CRIS Q2 2016 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena
CRIS
Curis, Inc.
$14M
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
$2M
94.3% margin
Operating Income
-$11M
-635.7% margin
Net Income
-$11M
-672.0% margin
EPS (Diluted)
$-8.73
QoQ Revenue Growth
-2.7%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$907,921
Balance Sheet
Total Assets
$74M
Total Liabilities
$28M
Stockholders' Equity
$46M
Cash & Equivalents
$9M
Revenue Segments
Drug Development Royalty
$274,000
100%
← FY 2016
All Quarters
Q3 2016 →